Marc Goodman
Stock Analyst at Leerink Partners
(4.87)
# 340
Out of 4,690 analysts
843
Total ratings
56.6%
Success rate
19.4%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGEN NervGen Pharma | Initiated Coverage: Buy | $10 | $2.28 | +338.60% | 1 | Jul 13, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $48.77 | +6.62% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | n/a | $31.62 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $24.04 | +45.59% | 1 | May 27, 2026 | |
| ACIU AC Immune | Maintained: Buy | n/a | $2.65 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Maintained: Hold | n/a | $47.41 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $26.42 | +58.97% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $97.93 | -23.41% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $1.39 | +475.54% | 1 | Jan 11, 2026 | |
| BHVN Biohaven | Maintained: Buy | $50 → $15 | $15.41 | -2.66% | 26 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.60 | +138.10% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.80 | +78.57% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $151.72 | -43.98% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $12.21 | +309.50% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $30 | $29.11 | +3.06% | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $218.50 | - | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $244.54 | -12.08% | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.99 | - | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $199.02 | - | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.88 | - | 42 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $34.74 | -42.43% | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $47.73 | -28.77% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $154.06 | - | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.03 | +396.28% | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $24.00 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.49 | n/a | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $40.98 | n/a | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $5.11 | n/a | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.33 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.0232 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $268.04 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $14.57 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $2.02 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $80.03 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $0.4644 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.04 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $52.23 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $153.84 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.54 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $291.50 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $541.69 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $794.19 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $66.58 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $16.34 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $27.96 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $20 | $36.44 | n/a | 26 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $148.35 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $255.48 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $14.48 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $1,174.61 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $17.54 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $145.68 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $4.13 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $8.78 | n/a | 24 | Mar 21, 2016 |
NervGen Pharma
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.28
Upside: +338.60%
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $48.77
Upside: +6.62%
Stoke Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $31.62
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $24.04
Upside: +45.59%
AC Immune
Apr 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.65
Upside: -
Alkermes
Mar 31, 2026
Maintained: Hold
Price Target: n/a
Current: $47.41
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $26.42
Upside: +58.97%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $97.93
Upside: -23.41%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.39
Upside: +475.54%
Biohaven
Dec 25, 2025
Maintained: Buy
Price Target: $50 → $15
Current: $15.41
Upside: -2.66%
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $12.60
Upside: +138.10%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.80
Upside: +78.57%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $151.72
Upside: -43.98%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $12.21
Upside: +309.50%
Oct 7, 2025
Maintained: Buy
Price Target: $32 → $30
Current: $29.11
Upside: +3.06%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $218.50
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $215
Current: $244.54
Upside: -12.08%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $59.99
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $199.02
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $8.88
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $10 → $20
Current: $34.74
Upside: -42.43%
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $47.73
Upside: -28.77%
Sep 23, 2025
Maintained: Buy
Price Target: n/a
Current: $154.06
Upside: -
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $4.03
Upside: +396.28%
Aug 13, 2025
Maintained: Buy
Price Target: $40
Current: $24.00
Upside: n/a
Aug 12, 2025
Maintained: Buy
Price Target: $10
Current: $1.49
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $40.98
Upside: n/a
Aug 1, 2025
Maintained: Buy
Price Target: $36
Current: $5.11
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: n/a
Current: $4.33
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.0232
Upside: n/a
Jan 13, 2025
Maintained: Buy
Price Target: n/a
Current: $268.04
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $4
Current: $14.57
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $2.02
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $20
Current: $80.03
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $70
Current: $0.4644
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: n/a
Current: $6.04
Upside: n/a
May 3, 2022
Maintained: Buy
Price Target: n/a
Current: $52.23
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: $25
Current: $153.84
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $42.54
Upside: n/a
Apr 5, 2021
Maintained: Buy
Price Target: $31
Current: $291.50
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $541.69
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $794.19
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $66.58
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $16.34
Upside: n/a
Jan 31, 2018
Maintained: Buy
Price Target: $42
Current: $27.96
Upside: n/a
Dec 18, 2017
Maintained: Hold
Price Target: $34 → $20
Current: $36.44
Upside: n/a
Oct 30, 2017
Maintained: Buy
Price Target: $67
Current: $148.35
Upside: n/a
Oct 13, 2017
Maintained: Hold
Price Target: $95
Current: $255.48
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $14.48
Upside: n/a
Jul 26, 2017
Maintained: Hold
Price Target: $85
Current: $1,174.61
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $17.54
Upside: n/a
Nov 2, 2016
Maintained: Buy
Price Target: $118
Current: $145.68
Upside: n/a
Jun 14, 2016
Maintained: Sell
Price Target: $8
Current: $4.13
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $8.78
Upside: n/a